RAPT Therapeutics, Inc. Balance Sheet
RAPT / Health Care|7 years of annual SEC 10-K data (FY2018-FY2024)
Shows total assets, cash and equivalents, receivables, property and equipment, total debt, and shareholders' equity across 7 fiscal years. All figures from audited SEC 10-K filings.
RAPT Therapeutics, Inc. had $240M in total assets and $190M in shareholders' equity as of FY2024.
Based on SEC 10-K filings.
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 0.38 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $169.7M | $47.5M | $38.9M | $24.0M | $24.9M | $77.4M | $63.8M |
| Current Assets | $235.2M | $161.8M | $252.7M | $193.0M | $115.6M | $80.5M | $65.1M |
| PP&E (Net) | $1.4M | $2.4M | $2.5M | $2.7M | $3.0M | $3.7M | $4.2M |
| Total Assets | $240.3M | $173.3M | $266.2M | $198.6M | $119.0M | $84.6M | $69.6M |
| Current Liabilities | $48.4M | $21.8M | $14.2M | $9.6M | $11.7M | $9.3M | $4.6M |
| Shareholders' Equity | $189.9M | $147.0M | $245.2M | $186.4M | $104.2M | $73.1M | -$97.1M |